ATEROSKLEROTIK KARDIOSKLEROZDA KARDIOMIOSITLAR GIPERTROFIYASIDAN ATROFIYASIGA O‘TISH YOSH CHEGARASI

Authors

DOI:

https://doi.org/10.5281/zenodo.24052598

Keywords:

cardiomyocyte, hypertrophy, atrophy, ocular micrometer, myocardial remodeling, age threshold

Abstract

The article addresses the determination of the age threshold for the transition from hypertrophy to atrophy of cardiomyocytes in atherosclerotic cardiosclerosis. This parameter is important for assessing the exhaustion of the myocardial compensatory reserve and for refining pathological conclusions. In autopsy material from 169 individuals who died of atherosclerotic cardiosclerosis, left ventricular cardiomyocyte diameter was measured with an ocular micrometer in ten age subgroups. The diameter increased from 24.5 µm at 25–30 years to 29.1±0.15 µm at 51–55 years. It then decreased, reaching 19.4±0.03 µm in individuals over 70. As a scientific novelty, the study shows that in atherosclerotic cardiosclerosis without infarction, the transition from hypertrophy to atrophy occurs at 55–60 years. In the authors’ view, the absence of hypertrophy in the elderly may indicate a decompensated stage of remodeling.

References

1. Avtandilov, G. G. (1990). Meditsinskaya morfometriya. Rukovodstvo. Meditsina.

2. Cohn, J. N., Ferrari, R., & Sharpe, N. (2000). Cardiac remodeling — concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol, 35(3), 569–582.

3. Frey, N., & Olson, E. N. (2003). Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol, 65, 45–79.

4. Gerdes, A. M., Kellerman, S. E., Moore, J. A., et al. (1992). Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation, 86(2), 426–430.

5. Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation, 107(2), 346–354.

6. Olivetti, G., Melissari, M., Capasso, J. M., & Anversa, P. (1991). Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res, 68(6), 1560–1568.

7. Olivetti, G., Giordano, G., Corradi, D., et al. (1995). Gender differences and aging: effects on the human heart. J Am Coll Cardiol, 26(4), 1068–1079.

Downloads

Published

2026-10-31

How to Cite

1.
Butayev S, Jumanov ZE, Pirmatov SV. ATEROSKLEROTIK KARDIOSKLEROZDA KARDIOMIOSITLAR GIPERTROFIYASIDAN ATROFIYASIGA O‘TISH YOSH CHEGARASI. TTI [Internet]. 2026 Oct. 31 [cited 2026 Nov. 18];2(10):727-30. Available from: https://tibbiyot-talimi-va-innovatsiyalari.uz/index.php/TTI/article/view/238
Vol. 2 No. 10 (2026): Journal of "Medical Education and Innovations"